Clinical Trial: Kesimpta (Ofatumumab) Pregnancy Registry
Study Status: Completed
Recruit Status: RECRUITING
Condition: Multiple Sclerosis
Study Type: OBSERVATIONAL
Official Title: Post-Authorization Safety Study for Assessment of Pregnancy and Infant Outcomes in Patients Treated With Kesimpta (Ofatumumab) Using OTIS Observational Pregnancy Surveillance Program and DMSKW Registr
Brief Summary:
The Kesimpta Pregnancy Registry is an observational, exposure cohort designed study to examine pregnancy and infant outcomes in women and infants who are exposed to Kesimpta (ofatumumab) during pregnancy to treat MS.
Read more